Pandemic Blamed for Failed Trial of Inhaled Antibiotic

Inhaled colistimethate sodium showed a large benefit in one trial but produced almost no effect in the other, a result attributed to the COVID pandemic.

Related Keywords

New York ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Eva Polverino ,Charles Haworth ,Cambridge Centre For Lung Infection ,World Bronchiectasis ,Cambridge Centre ,Lung Infection ,Royal Papworth Hospital ,Hospital Clinic ,Antibiotics ,Igecycline ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Drug Development ,Pandemic ,Drug Treatment Safety ,Bronchiectasis ,Treatment Guidelines ,Quality Of Life ,Pol ,Ealth Related Quality Of Life ,Rqol ,Cystic Fibrosis ,Clinical Guidelines , ,